-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Sigilon Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2020 to Q2 2023.
- Sigilon Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2023 was 2.5M shares, a 0.39% increase year-over-year.
- Sigilon Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 32.4M shares, a 1.71% increase from 2021.
- Sigilon Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 31.9M shares, a 341% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)